These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 29137811)

  • 1. Improving the safety of metal-based drugs by tuning their metabolism with chemoprotective agents.
    Gailer J
    J Inorg Biochem; 2018 Feb; 179():154-157. PubMed ID: 29137811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprotection by D-methionine against cisplatin-induced side-effects: insight from in vitro studies using human plasma.
    Sooriyaarachchi M; White WM; Narendran A; Gailer J
    Metallomics; 2014 Mar; 6(3):532-41. PubMed ID: 24337005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuning the metabolism of the anticancer drug cisplatin with chemoprotective agents to improve its safety and efficacy.
    Sooriyaarachchi M; George GN; Pickering IJ; Narendran A; Gailer J
    Metallomics; 2016 Nov; 8(11):1170-1176. PubMed ID: 27722429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetyl-L-cysteine modulates the metabolism of cis-platin in human plasma in vitro.
    Sooriyaarachchi M; Narendran A; Gailer J
    Metallomics; 2013 Mar; 5(3):197-207. PubMed ID: 23443244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of sodium thiosulfate on the metabolism of cis-platin in human plasma in vitro.
    Sooriyaarachchi M; Narendran A; Gailer J
    Metallomics; 2012 Aug; 4(9):960-7. PubMed ID: 22842879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescue from enhanced alkylator-induced cell death with low molecular weight sulfur-containing chemoprotectants.
    Muldoon LL; Walker-Rosenfeld SL; Hale C; Purcell SE; Bennett LC; Neuwelt EA
    J Pharmacol Exp Ther; 2001 Mar; 296(3):797-805. PubMed ID: 11181909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fortification of blood plasma from cancer patients with human serum albumin decreases the concentration of cisplatin-derived toxic hydrolysis products in vitro.
    Morris TT; Ruan Y; Lewis VA; Narendran A; Gailer J
    Metallomics; 2014 Nov; 6(11):2034-41. PubMed ID: 25255207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of Cisplatin and its monohydrated complex with sulfur-containing compounds designed for local otoprotective administration.
    Videhult P; Laurell G; Wallin I; Ehrsson H
    Exp Biol Med (Maywood); 2006 Nov; 231(10):1638-45. PubMed ID: 17060685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative hydrolysis and plasma protein binding of cis-platin and carboplatin in human plasma in vitro.
    Sooriyaarachchi M; Narendran A; Gailer J
    Metallomics; 2011 Jan; 3(1):49-55. PubMed ID: 21135941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a Novel Metallomics Tool to Probe the Fate of Metal-Based Anticancer Drugs in Blood Plasma: Potential, Challenges and Prospects.
    Sarpong-Kumankomah S; Gailer J
    Curr Top Med Chem; 2021; 21(1):48-58. PubMed ID: 32600232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical basis for the detoxification of cisplatin-derived hydrolysis products by sodium thiosulfate.
    Sooriyaarachchi M; Gailer J; Dolgova NV; Pickering IJ; George GN
    J Inorg Biochem; 2016 Sep; 162():96-101. PubMed ID: 27324827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels.
    Dickey DT; Wu YJ; Muldoon LL; Neuwelt EA
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1052-8. PubMed ID: 15951398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and pharmacological screening of novel renoprotective methionine-based peptidomimetics: Amelioration of cisplatin-induced nephrotoxicity.
    Agha KA; Ibrahim TS; Elsherbiny NM; El-Sherbiny M; Abdel-Aal EH; Abdel-Samii ZK; Abo-Dya NE
    Bioorg Chem; 2021 Sep; 114():105100. PubMed ID: 34246972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway.
    Wu YJ; Muldoon LL; Neuwelt EA
    J Pharmacol Exp Ther; 2005 Feb; 312(2):424-31. PubMed ID: 15496615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprotective effect of Ixora coccinea L. flowers on cisplatin induced toxicity in mice.
    Latha PG; Panikkar KR
    Phytother Res; 2001 Jun; 15(4):364-6. PubMed ID: 11406864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfur-containing amino acids decrease cisplatin cytotoxicity and uptake in renal tubule epithelial cell lines.
    Kröning R; Lichtenstein AK; Nagami GT
    Cancer Chemother Pharmacol; 2000; 45(1):43-9. PubMed ID: 10647500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reaction of a platinated methionine motif of CTR1 with cysteine and histidine is dependent upon the type of precursor platinum complex.
    Ma G; Wu Q; Wu X; Arnesano F; Natile G; Sletten E; Liu Y
    J Inorg Biochem; 2015 Dec; 153():239-246. PubMed ID: 26235215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fast cleavage of a diselenide induced by a platinum(II)-methionine complex and its biological implications.
    Liu Q; Wang X; Yang X; Liang X; Guo Z
    J Inorg Biochem; 2010 Nov; 104(11):1178-84. PubMed ID: 20705343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential chemoprotective role of resveratrol against cisplatin induced testicular damage in mice.
    Singh I; Goyal Y; Ranawat P
    Chem Biol Interact; 2017 Aug; 273():200-211. PubMed ID: 28606469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
    Jain N; Lam YM; Pym J; Campling BG
    Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.